MetP Pharma Announces Preclinical Research Results of semaglutide Development
MetP Pharma has announced its preclinical research results that strongly support the further development of semaglutide in an oleogel formulation using the BrainDos drug delivery technology.
BrainDos Drug Delivery Technology | 09/05/2024 | By Aishwarya | 533
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy